Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1372052Generated: October 26, 2026

1-(4-Methoxyphenyl)piperazine → 2-(4-Chloro-5-methyl-3-trifluoromethyl-pyrazol-1-yl)-1-[4-(4-methoxyphenyl)-piperazin-1-yl]-ethanone

https://huagongshe.com/reaction/1372052

Reaction equation

Participants

RoleNameHCIDCharge
Reactant1-(4-Methoxyphenyl)piperazineHCID 269722—
Reactant(4-Chloro-5-methyl-3-trifluoromethyl-pyrazol-1-yl)-acetic acidHCID 1876853—
ReactantMethanaminium, N-((dimethylamino)(3H-1,2,3-triazolo(4,5-b)pyridin-3-yloxy)methylene)-N-methyl-, hexafluorophosphate(1-) (1:1)HCID 9886157—
Product2-(4-Chloro-5-methyl-3-trifluoromethyl-pyrazol-1-yl)-1-[4-(4-methoxyphenyl)-piperazin-1-yl]-ethanoneHCID 21071096—

Reaction Steps

Title compound was prepared following the HATU mediated coupling protocol P, wherein 1-(4-Methoxyphenyl)-piperazine and (4-Chloro-5-methyl-3-trifluoromethyl-pyrazol-1-yl)-acetic acid were used as the coupling components, to give the product as a solid: 1H NMR (CDCl3, 400 MHz) 6.88 (m, 4H), 5.00 (s, 2H), 3.78 (m, 3H), 3.76 (m, 2H), 3.70 (m, 2H), 3.08 (m, 4H), 2.30 (s, 3H) ppm; MS (ES) M+Na expected=439.0, found 439.0.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS07157464B2
Source datasetuspto-grants-2007_01
ORD IDord-b158fa1fee0e4558a58b9c2c6f47f9a0
Source noteuspto-grants-2007_01